#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=The development of nanostructures that mimic the remarkable functions and catalytic properties of natural enzymes , i. e. , to create nanozymes , has been an exciting topic in the field of nanotechnology for the last two decades .
2-1	16-19	The	abstract[2]	new[2]	coref	2-26[8_2]
2-2	20-31	development	abstract[2]	new[2]	_	_
2-3	32-34	of	abstract[2]	new[2]	_	_
2-4	35-49	nanostructures	abstract[2]|object	new[2]|new	_	_
2-5	50-54	that	_	_	_	_
2-6	55-60	mimic	_	_	_	_
2-7	61-64	the	abstract[4]	new[4]	_	_
2-8	65-75	remarkable	abstract[4]	new[4]	_	_
2-9	76-85	functions	abstract[4]	new[4]	_	_
2-10	86-89	and	_	_	_	_
2-11	90-99	catalytic	abstract[5]	new[5]	_	_
2-12	100-110	properties	abstract[5]	new[5]	_	_
2-13	111-113	of	abstract[5]	new[5]	_	_
2-14	114-121	natural	abstract[5]|substance[6]	new[5]|new[6]	_	_
2-15	122-129	enzymes	abstract[5]|substance[6]	new[5]|new[6]	_	_
2-16	130-131	,	abstract[5]	new[5]	_	_
2-17	132-134	i.	abstract[5]	new[5]	_	_
2-18	135-137	e.	abstract[5]	new[5]	_	_
2-19	138-139	,	_	_	_	_
2-20	140-142	to	_	_	_	_
2-21	143-149	create	_	_	_	_
2-22	150-159	nanozymes	object	new	coref	3-7[13_0]
2-23	160-161	,	_	_	_	_
2-24	162-165	has	_	_	_	_
2-25	166-170	been	_	_	_	_
2-26	171-173	an	abstract[8]	giv[8]	_	_
2-27	174-182	exciting	abstract[8]	giv[8]	_	_
2-28	183-188	topic	abstract[8]	giv[8]	_	_
2-29	189-191	in	abstract[8]	giv[8]	_	_
2-30	192-195	the	abstract[8]|abstract[9]	giv[8]|new[9]	_	_
2-31	196-201	field	abstract[8]|abstract[9]	giv[8]|new[9]	_	_
2-32	202-204	of	abstract[8]|abstract[9]	giv[8]|new[9]	_	_
2-33	205-219	nanotechnology	abstract[8]|abstract[9]|abstract	giv[8]|new[9]|new	_	_
2-34	220-223	for	abstract[8]	giv[8]	_	_
2-35	224-227	the	abstract[8]|time[11]	giv[8]|new[11]	_	_
2-36	228-232	last	abstract[8]|time[11]	giv[8]|new[11]	_	_
2-37	233-236	two	abstract[8]|time[11]	giv[8]|new[11]	_	_
2-38	237-244	decades	abstract[8]|time[11]	giv[8]|new[11]	_	_
2-39	245-246	.	_	_	_	_

#Text=Among several approaches used to create nanozymes , the self-assembly of thiolated ligands onto the surface of gold nanoparticles ( Au-NPs ) to obtain monolayer-protected gold clusters ( Au-MPCs ) has emerged as a powerful strategy .
3-1	247-252	Among	_	_	_	_
3-2	253-260	several	abstract[12]	new[12]	coref	14-23[143_12]
3-3	261-271	approaches	abstract[12]	new[12]	_	_
3-4	272-276	used	_	_	_	_
3-5	277-279	to	_	_	_	_
3-6	280-286	create	_	_	_	_
3-7	287-296	nanozymes	object[13]	giv[13]	_	_
3-8	297-298	,	object[13]	giv[13]	_	_
3-9	299-302	the	object[13]|substance[14]	giv[13]|new[14]	_	_
3-10	303-316	self-assembly	object[13]|substance[14]	giv[13]|new[14]	_	_
3-11	317-319	of	object[13]|substance[14]	giv[13]|new[14]	_	_
3-12	320-329	thiolated	object[13]|substance[14]	giv[13]|new[14]	_	_
3-13	330-337	ligands	object[13]|substance[14]	giv[13]|new[14]	_	_
3-14	338-342	onto	object[13]|substance[14]	giv[13]|new[14]	_	_
3-15	343-346	the	object[13]|substance[14]|place[15]	giv[13]|new[14]|new[15]	coref	4-10[24_15]
3-16	347-354	surface	object[13]|substance[14]|place[15]	giv[13]|new[14]|new[15]	_	_
3-17	355-357	of	object[13]|substance[14]|place[15]	giv[13]|new[14]|new[15]	_	_
3-18	358-362	gold	object[13]|substance[14]|place[15]|substance|abstract[17]	giv[13]|new[14]|new[15]|new|new[17]	appos|coref	3-21[0_17]|3-26
3-19	363-376	nanoparticles	object[13]|substance[14]|place[15]|abstract[17]	giv[13]|new[14]|new[15]|new[17]	_	_
3-20	377-378	(	_	_	_	_
3-21	379-385	Au-NPs	abstract	giv	coref	4-13[26_0]
3-22	386-387	)	_	_	_	_
3-23	388-390	to	_	_	_	_
3-24	391-397	obtain	_	_	_	_
3-25	398-417	monolayer-protected	abstract[20]	new[20]	appos	3-29[0_20]
3-26	418-422	gold	substance|abstract[20]	giv|new[20]	coref	4-13
3-27	423-431	clusters	abstract[20]	new[20]	_	_
3-28	432-433	(	_	_	_	_
3-29	434-441	Au-MPCs	abstract	giv	_	_
3-30	442-443	)	_	_	_	_
3-31	444-447	has	_	_	_	_
3-32	448-455	emerged	_	_	_	_
3-33	456-458	as	_	_	_	_
3-34	459-460	a	_	_	_	_
3-35	461-469	powerful	_	_	_	_
3-36	470-478	strategy	_	_	_	_
3-37	479-480	.	_	_	_	_

#Text=In particular , the conjugation of peptides on to the surface of gold nanoparticles to yield peptide – gold nanoparticle conjugates ( Pep-Au-NPs ) expanded the possibilities for the design of artificial enzymes .
4-1	481-483	In	_	_	_	_
4-2	484-494	particular	_	_	_	_
4-3	495-496	,	_	_	_	_
4-4	497-500	the	abstract[22]	new[22]	_	_
4-5	501-512	conjugation	abstract[22]	new[22]	_	_
4-6	513-515	of	abstract[22]	new[22]	_	_
4-7	516-524	peptides	abstract[22]|substance	new[22]|new	coref	5-1
4-8	525-527	on	abstract[22]	new[22]	_	_
4-9	528-530	to	abstract[22]	new[22]	_	_
4-10	531-534	the	abstract[22]|object[24]	new[22]|giv[24]	_	_
4-11	535-542	surface	abstract[22]|object[24]	new[22]|giv[24]	_	_
4-12	543-545	of	abstract[22]|object[24]	new[22]|giv[24]	_	_
4-13	546-550	gold	abstract[22]|object[24]|substance|object[26]	new[22]|giv[24]|giv|giv[26]	coref|coref	4-19|6-6[0_26]
4-14	551-564	nanoparticles	abstract[22]|object[24]|object[26]	new[22]|giv[24]|giv[26]	_	_
4-15	565-567	to	_	_	_	_
4-16	568-573	yield	_	_	_	_
4-17	574-581	peptide	substance	new	coref	5-9
4-18	582-583	–	_	_	_	_
4-19	584-588	gold	substance|object[30]	giv|new[30]	appos	4-23[0_30]
4-20	589-601	nanoparticle	quantity|object[30]	new|new[30]	_	_
4-21	602-612	conjugates	object[30]	new[30]	_	_
4-22	613-614	(	_	_	_	_
4-23	615-625	Pep-Au-NPs	object	giv	coref	9-9
4-24	626-627	)	_	_	_	_
4-25	628-636	expanded	_	_	_	_
4-26	637-640	the	abstract[32]	new[32]	_	_
4-27	641-654	possibilities	abstract[32]	new[32]	_	_
4-28	655-658	for	abstract[32]	new[32]	_	_
4-29	659-662	the	abstract[32]|abstract[33]	new[32]|new[33]	coref	5-13[40_33]
4-30	663-669	design	abstract[32]|abstract[33]	new[32]|new[33]	_	_
4-31	670-672	of	abstract[32]|abstract[33]	new[32]|new[33]	_	_
4-32	673-683	artificial	abstract[32]|abstract[33]|object[34]	new[32]|new[33]|new[34]	ana	5-13[0_34]
4-33	684-691	enzymes	abstract[32]|abstract[33]|object[34]	new[32]|new[33]|new[34]	_	_
4-34	692-693	.	_	_	_	_

#Text=Peptides are available at low cost by solid-phase peptide synthesis , and their modular design paired with the available repertoire of natural and non-natural amino acids allows for facile diversification of functional groups , and thus the resulting catalytic activities and substrate specificities of the peptide shell .
5-1	694-702	Peptides	object	giv	coref	6-4[52_0]
5-2	703-706	are	_	_	_	_
5-3	707-716	available	_	_	_	_
5-4	717-719	at	_	_	_	_
5-5	720-723	low	abstract[36]	new[36]	_	_
5-6	724-728	cost	abstract[36]	new[36]	_	_
5-7	729-731	by	abstract[36]	new[36]	_	_
5-8	732-743	solid-phase	abstract[36]|abstract[38]	new[36]|new[38]	coref	15-31[156_38]
5-9	744-751	peptide	abstract[36]|abstract|abstract[38]	new[36]|giv|new[38]	coref	5-46
5-10	752-761	synthesis	abstract[36]|abstract[38]	new[36]|new[38]	_	_
5-11	762-763	,	_	_	_	_
5-12	764-767	and	_	_	_	_
5-13	768-773	their	object|abstract[40]	giv|giv[40]	coref	9-4[74_40]
5-14	774-781	modular	abstract[40]	giv[40]	_	_
5-15	782-788	design	abstract[40]	giv[40]	_	_
5-16	789-795	paired	_	_	_	_
5-17	796-800	with	_	_	_	_
5-18	801-804	the	abstract[41]	new[41]	_	_
5-19	805-814	available	abstract[41]	new[41]	_	_
5-20	815-825	repertoire	abstract[41]	new[41]	_	_
5-21	826-828	of	abstract[41]	new[41]	_	_
5-22	829-836	natural	abstract[41]|substance[43]	new[41]|new[43]	_	_
5-23	837-840	and	abstract[41]|substance[43]	new[41]|new[43]	_	_
5-24	841-852	non-natural	abstract[41]|substance[43]	new[41]|new[43]	_	_
5-25	853-858	amino	abstract[41]|object|substance[43]	new[41]|new|new[43]	_	_
5-26	859-864	acids	abstract[41]|substance[43]	new[41]|new[43]	_	_
5-27	865-871	allows	_	_	_	_
5-28	872-875	for	_	_	_	_
5-29	876-882	facile	abstract[44]	new[44]	_	_
5-30	883-898	diversification	abstract[44]	new[44]	_	_
5-31	899-901	of	abstract[44]	new[44]	_	_
5-32	902-912	functional	abstract[44]|abstract[45]	new[44]|new[45]	coref	7-15[65_45]
5-33	913-919	groups	abstract[44]|abstract[45]	new[44]|new[45]	_	_
5-34	920-921	,	_	_	_	_
5-35	922-925	and	_	_	_	_
5-36	926-930	thus	abstract[46]	new[46]	_	_
5-37	931-934	the	abstract[46]	new[46]	_	_
5-38	935-944	resulting	abstract[46]	new[46]	_	_
5-39	945-954	catalytic	abstract[46]	new[46]	_	_
5-40	955-965	activities	abstract[46]	new[46]	_	_
5-41	966-969	and	_	_	_	_
5-42	970-979	substrate	person|abstract[48]	new|new[48]	coref	7-20
5-43	980-993	specificities	abstract[48]	new[48]	_	_
5-44	994-996	of	abstract[48]	new[48]	_	_
5-45	997-1000	the	abstract[48]|object[50]	new[48]|new[50]	_	_
5-46	1001-1008	peptide	abstract[48]|abstract|object[50]	new[48]|giv|new[50]	coref	6-10
5-47	1009-1014	shell	abstract[48]|object[50]	new[48]|new[50]	_	_
5-48	1015-1016	.	_	_	_	_

#Text=The conjunction of peptides and Au-NPs leads to dense peptide monolayers in which new hydrogen bond and/or charge interactions between individual peptides are established .
6-1	1017-1020	The	abstract[51]	new[51]	_	_
6-2	1021-1032	conjunction	abstract[51]	new[51]	_	_
6-3	1033-1035	of	abstract[51]	new[51]	_	_
6-4	1036-1044	peptides	abstract[51]|substance[52]	new[51]|giv[52]	coref	6-21[59_52]
6-5	1045-1048	and	abstract[51]|substance[52]	new[51]|giv[52]	_	_
6-6	1049-1055	Au-NPs	abstract[51]|substance[52]|abstract	new[51]|giv[52]|giv	_	_
6-7	1056-1061	leads	_	_	_	_
6-8	1062-1064	to	_	_	_	_
6-9	1065-1070	dense	object[55]	new[55]	_	_
6-10	1071-1078	peptide	place|object[55]	giv|new[55]	coref	8-15[72_0]
6-11	1079-1089	monolayers	object[55]	new[55]	_	_
6-12	1090-1092	in	_	_	_	_
6-13	1093-1098	which	_	_	_	_
6-14	1099-1102	new	abstract[57]	new[57]	ana	7-1[0_57]
6-15	1103-1111	hydrogen	substance|abstract[57]	new|new[57]	_	_
6-16	1112-1116	bond	abstract[57]	new[57]	_	_
6-17	1117-1123	and/or	_	_	_	_
6-18	1124-1130	charge	_	_	_	_
6-19	1131-1143	interactions	abstract[58]	new[58]	_	_
6-20	1144-1151	between	abstract[58]	new[58]	_	_
6-21	1152-1162	individual	abstract[58]|substance[59]	new[58]|giv[59]	_	_
6-22	1163-1171	peptides	abstract[58]|substance[59]	new[58]|giv[59]	_	_
6-23	1172-1175	are	_	_	_	_
6-24	1176-1187	established	_	_	_	_
6-25	1188-1189	.	_	_	_	_

#Text=This enables known enzyme-like effects , such as the perturbation of pKa values of functional groups and cooperativity in substrate binding , and can even lead to new catalytic mechanisms .
7-1	1190-1194	This	abstract	giv	_	_
7-2	1195-1202	enables	_	_	_	_
7-3	1203-1208	known	abstract[61]	new[61]	coref	8-3[70_61]
7-4	1209-1220	enzyme-like	abstract[61]	new[61]	_	_
7-5	1221-1228	effects	abstract[61]	new[61]	_	_
7-6	1229-1230	,	abstract[61]	new[61]	_	_
7-7	1231-1235	such	abstract[61]	new[61]	_	_
7-8	1236-1238	as	abstract[61]	new[61]	_	_
7-9	1239-1242	the	abstract[61]|abstract[62]	new[61]|new[62]	_	_
7-10	1243-1255	perturbation	abstract[61]|abstract[62]	new[61]|new[62]	_	_
7-11	1256-1258	of	abstract[61]|abstract[62]	new[61]|new[62]	_	_
7-12	1259-1262	pKa	abstract[61]|abstract[62]|quantity|abstract[64]	new[61]|new[62]|new|new[64]	coref	12-40[121_0]
7-13	1263-1269	values	abstract[61]|abstract[62]|abstract[64]	new[61]|new[62]|new[64]	_	_
7-14	1270-1272	of	abstract[61]|abstract[62]|abstract[64]	new[61]|new[62]|new[64]	_	_
7-15	1273-1283	functional	abstract[61]|abstract[62]|abstract[64]|abstract[65]	new[61]|new[62]|new[64]|giv[65]	_	_
7-16	1284-1290	groups	abstract[61]|abstract[62]|abstract[64]|abstract[65]	new[61]|new[62]|new[64]|giv[65]	_	_
7-17	1291-1294	and	abstract[61]|abstract[62]|abstract[64]|abstract[65]	new[61]|new[62]|new[64]|giv[65]	_	_
7-18	1295-1308	cooperativity	abstract[61]|abstract[62]|abstract[64]|abstract[65]|event[66]	new[61]|new[62]|new[64]|giv[65]|new[66]	_	_
7-19	1309-1311	in	abstract[61]|abstract[62]|abstract[64]|abstract[65]|event[66]	new[61]|new[62]|new[64]|giv[65]|new[66]	_	_
7-20	1312-1321	substrate	abstract[61]|abstract[62]|abstract[64]|abstract[65]|event[66]|object|event[68]	new[61]|new[62]|new[64]|giv[65]|new[66]|giv|new[68]	_	_
7-21	1322-1329	binding	abstract[61]|abstract[62]|abstract[64]|abstract[65]|event[66]|event[68]	new[61]|new[62]|new[64]|giv[65]|new[66]|new[68]	_	_
7-22	1330-1331	,	_	_	_	_
7-23	1332-1335	and	_	_	_	_
7-24	1336-1339	can	_	_	_	_
7-25	1340-1344	even	_	_	_	_
7-26	1345-1349	lead	_	_	_	_
7-27	1350-1352	to	_	_	_	_
7-28	1353-1356	new	abstract[69]	new[69]	_	_
7-29	1357-1366	catalytic	abstract[69]	new[69]	_	_
7-30	1367-1377	mechanisms	abstract[69]	new[69]	_	_
7-31	1378-1379	.	_	_	_	_

#Text=Altogether , these effects can greatly improve the catalytic performance of a conjugated versus an unconjugated peptide .
8-1	1380-1390	Altogether	_	_	_	_
8-2	1391-1392	,	_	_	_	_
8-3	1393-1398	these	abstract[70]	giv[70]	_	_
8-4	1399-1406	effects	abstract[70]	giv[70]	_	_
8-5	1407-1410	can	_	_	_	_
8-6	1411-1418	greatly	_	_	_	_
8-7	1419-1426	improve	_	_	_	_
8-8	1427-1430	the	abstract[71]	new[71]	_	_
8-9	1431-1440	catalytic	abstract[71]	new[71]	_	_
8-10	1441-1452	performance	abstract[71]	new[71]	_	_
8-11	1453-1455	of	abstract[71]	new[71]	_	_
8-12	1456-1457	a	abstract[71]	new[71]	_	_
8-13	1458-1468	conjugated	abstract[71]	new[71]	_	_
8-14	1469-1475	versus	_	_	_	_
8-15	1476-1478	an	substance[72]	giv[72]	_	_
8-16	1479-1491	unconjugated	substance[72]	giv[72]	_	_
8-17	1492-1499	peptide	substance[72]	giv[72]	_	_
8-18	1500-1501	.	_	_	_	_

#Text=To date , the design and application of Pep-Au-NPs have been limited to organic esterase chemistry , in which catalysis is mediated by a His-imidazole .
9-1	1502-1504	To	_	_	_	_
9-2	1505-1509	date	time	new	_	_
9-3	1510-1511	,	_	_	_	_
9-4	1512-1515	the	abstract[74]|abstract[75]	giv[74]|new[75]	coref	15-28[155_75]
9-5	1516-1522	design	abstract[74]|abstract[75]	giv[74]|new[75]	_	_
9-6	1523-1526	and	abstract[75]	new[75]	_	_
9-7	1527-1538	application	abstract[75]|abstract[76]	new[75]|new[76]	coref	14-2[136_76]
9-8	1539-1541	of	abstract[75]|abstract[76]	new[75]|new[76]	_	_
9-9	1542-1552	Pep-Au-NPs	abstract[75]|abstract[76]|object	new[75]|new[76]|giv	coref	15-12
9-10	1553-1557	have	_	_	_	_
9-11	1558-1562	been	_	_	_	_
9-12	1563-1570	limited	_	_	_	_
9-13	1571-1573	to	_	_	_	_
9-14	1574-1581	organic	abstract[79]	new[79]	_	_
9-15	1582-1590	esterase	object|abstract[79]	new|new[79]	_	_
9-16	1591-1600	chemistry	abstract[79]	new[79]	_	_
9-17	1601-1602	,	_	_	_	_
9-18	1603-1605	in	_	_	_	_
9-19	1606-1611	which	abstract[80]	new[80]	_	_
9-20	1612-1621	catalysis	abstract[80]	new[80]	_	_
9-21	1622-1624	is	_	_	_	_
9-22	1625-1633	mediated	_	_	_	_
9-23	1634-1636	by	_	_	_	_
9-24	1637-1638	a	substance[81]	new[81]	_	_
9-25	1639-1652	His-imidazole	substance[81]	new[81]	_	_
9-26	1653-1654	.	_	_	_	_

#Text=Considering the fact that zinc metalloenzymes perform numerous other types of reactions in nature , including phosphodiester and amide hydrolysis as well as the ( de)hydrogenation of alcohols , it is of great interest to reconstitute such transformations in vitro by developing appropriate robust synthetic systems .
10-1	1655-1666	Considering	_	_	_	_
10-2	1667-1670	the	abstract[82]	new[82]	_	_
10-3	1671-1675	fact	abstract[82]	new[82]	_	_
10-4	1676-1680	that	abstract[82]	new[82]	_	_
10-5	1681-1685	zinc	abstract[82]|substance|substance[84]	new[82]|new|new[84]	coref	11-13
10-6	1686-1700	metalloenzymes	abstract[82]|substance[84]	new[82]|new[84]	_	_
10-7	1701-1708	perform	abstract[82]	new[82]	_	_
10-8	1709-1717	numerous	abstract[82]|place[85]	new[82]|new[85]	_	_
10-9	1718-1723	other	abstract[82]|place[85]	new[82]|new[85]	_	_
10-10	1724-1729	types	abstract[82]|place[85]	new[82]|new[85]	_	_
10-11	1730-1732	of	abstract[82]|place[85]	new[82]|new[85]	_	_
10-12	1733-1742	reactions	abstract[82]|place[85]|event[86]	new[82]|new[85]|new[86]	_	_
10-13	1743-1745	in	abstract[82]|place[85]|event[86]	new[82]|new[85]|new[86]	_	_
10-14	1746-1752	nature	abstract[82]|place[85]|event[86]|abstract	new[82]|new[85]|new[86]|new	_	_
10-15	1753-1754	,	abstract[82]|place[85]|event[86]	new[82]|new[85]|new[86]	_	_
10-16	1755-1764	including	abstract[82]|place[85]|event[86]	new[82]|new[85]|new[86]	_	_
10-17	1765-1779	phosphodiester	abstract[82]|place[85]|event[86]|substance|substance[90]	new[82]|new[85]|new[86]|new|new[90]	_	_
10-18	1780-1783	and	abstract[82]|place[85]|event[86]|substance[90]	new[82]|new[85]|new[86]|new[90]	_	_
10-19	1784-1789	amide	abstract[82]|place[85]|event[86]|substance|substance[90]	new[82]|new[85]|new[86]|new|new[90]	_	_
10-20	1790-1800	hydrolysis	abstract[82]|place[85]|event[86]|substance[90]	new[82]|new[85]|new[86]|new[90]	_	_
10-21	1801-1803	as	abstract[82]	new[82]	_	_
10-22	1804-1808	well	abstract[82]	new[82]	_	_
10-23	1809-1811	as	abstract[82]	new[82]	_	_
10-24	1812-1815	the	abstract[82]|event[91]	new[82]|new[91]	ana	10-30[0_91]
10-25	1816-1817	(	abstract[82]|event[91]	new[82]|new[91]	_	_
10-26	1818-1834	de)hydrogenation	abstract[82]|event[91]	new[82]|new[91]	_	_
10-27	1835-1837	of	abstract[82]|event[91]	new[82]|new[91]	_	_
10-28	1838-1846	alcohols	abstract[82]|event[91]|substance	new[82]|new[91]|new	_	_
10-29	1847-1848	,	_	_	_	_
10-30	1849-1851	it	event	giv	_	_
10-31	1852-1854	is	_	_	_	_
10-32	1855-1857	of	_	_	_	_
10-33	1858-1863	great	abstract[94]	new[94]	coref	14-6[138_94]
10-34	1864-1872	interest	abstract[94]	new[94]	_	_
10-35	1873-1875	to	_	_	_	_
10-36	1876-1888	reconstitute	_	_	_	_
10-37	1889-1893	such	abstract[95]	new[95]	_	_
10-38	1894-1909	transformations	abstract[95]	new[95]	_	_
10-39	1910-1912	in	abstract[95]	new[95]	_	_
10-40	1913-1918	vitro	abstract[95]	new[95]	_	_
10-41	1919-1921	by	_	_	_	_
10-42	1922-1932	developing	_	_	_	_
10-43	1933-1944	appropriate	abstract[96]	new[96]	coref	13-26[135_96]
10-44	1945-1951	robust	abstract[96]	new[96]	_	_
10-45	1952-1961	synthetic	abstract[96]	new[96]	_	_
10-46	1962-1969	systems	abstract[96]	new[96]	_	_
10-47	1970-1971	.	_	_	_	_

#Text=For example , carbonic anhydrase ( CA ) is a naturally occurring zinc metalloenzyme that efficiently and reversibly catalyzes the hydration of CO2 into hydrogen carbonate ( HCO3− ) .
11-1	1972-1975	For	_	_	_	_
11-2	1976-1983	example	_	_	_	_
11-3	1984-1985	,	_	_	_	_
11-4	1986-1994	carbonic	abstract|substance[98]	new|new[98]	coref|coref	11-10[101_98]|15-38
11-5	1995-2004	anhydrase	substance[98]	new[98]	_	_
11-6	2005-2006	(	_	_	_	_
11-7	2007-2009	CA	object	new	ana	12-1
11-8	2010-2011	)	_	_	_	_
11-9	2012-2014	is	_	_	_	_
11-10	2015-2016	a	substance[101]	giv[101]	coref	15-33[158_101]
11-11	2017-2026	naturally	substance[101]	giv[101]	_	_
11-12	2027-2036	occurring	substance[101]	giv[101]	_	_
11-13	2037-2041	zinc	substance|substance[101]	giv|giv[101]	coref	12-6[109_0]
11-14	2042-2055	metalloenzyme	substance[101]	giv[101]	_	_
11-15	2056-2060	that	_	_	_	_
11-16	2061-2072	efficiently	_	_	_	_
11-17	2073-2076	and	_	_	_	_
11-18	2077-2087	reversibly	_	_	_	_
11-19	2088-2097	catalyzes	_	_	_	_
11-20	2098-2101	the	substance[102]	new[102]	_	_
11-21	2102-2111	hydration	substance[102]	new[102]	_	_
11-22	2112-2114	of	substance[102]	new[102]	_	_
11-23	2115-2118	CO2	substance[102]|substance	new[102]|new	coref	12-56
11-24	2119-2123	into	_	_	_	_
11-25	2124-2132	hydrogen	abstract[104]	new[104]	appos	11-28[0_104]
11-26	2133-2142	carbonate	abstract[104]	new[104]	_	_
11-27	2143-2144	(	_	_	_	_
11-28	2145-2150	HCO3−	abstract	giv	coref	12-65
11-29	2151-2152	)	_	_	_	_
11-30	2153-2154	.	_	_	_	_

#Text=Its high activity originates from its zinc ( Zn(II ) ) containing active site , in which three histidine imidazole moieties coordinate a Zn(II)-ion leaving a vacant space for the association of a water molecule . Zn(II ) lowers the pKa of the bound water and forms a highly nucleophilic hydroxide species which reacts with CO2 , bound in close proximity , to yield HCO3− .
12-1	2155-2158	Its	object|abstract[107]	giv|new[107]	ana|coref	12-6|15-38[161_107]
12-2	2159-2163	high	abstract[107]	new[107]	_	_
12-3	2164-2172	activity	abstract[107]	new[107]	_	_
12-4	2173-2183	originates	_	_	_	_
12-5	2184-2188	from	_	_	_	_
12-6	2189-2192	its	substance|abstract[109]	giv|giv[109]	appos	12-9[0_109]
12-7	2193-2197	zinc	abstract[109]	giv[109]	_	_
12-8	2198-2199	(	_	_	_	_
12-9	2200-2205	Zn(II	abstract	giv	coref	12-37
12-10	2206-2207	)	_	_	_	_
12-11	2208-2209	)	_	_	_	_
12-12	2210-2220	containing	_	_	_	_
12-13	2221-2227	active	place[111]	new[111]	_	_
12-14	2228-2232	site	place[111]	new[111]	_	_
12-15	2233-2234	,	_	_	_	_
12-16	2235-2237	in	_	_	_	_
12-17	2238-2243	which	_	_	_	_
12-18	2244-2249	three	substance[114]	new[114]	_	_
12-19	2250-2259	histidine	substance|substance[114]	new|new[114]	_	_
12-20	2260-2269	imidazole	object|substance[114]	new|new[114]	_	_
12-21	2270-2278	moieties	substance[114]	new[114]	_	_
12-22	2279-2289	coordinate	_	_	_	_
12-23	2290-2291	a	substance[115]	new[115]	_	_
12-24	2292-2302	Zn(II)-ion	substance[115]	new[115]	_	_
12-25	2303-2310	leaving	_	_	_	_
12-26	2311-2312	a	place[116]	new[116]	_	_
12-27	2313-2319	vacant	place[116]	new[116]	_	_
12-28	2320-2325	space	place[116]	new[116]	_	_
12-29	2326-2329	for	_	_	_	_
12-30	2330-2333	the	event[117]	new[117]	_	_
12-31	2334-2345	association	event[117]	new[117]	_	_
12-32	2346-2348	of	event[117]	new[117]	_	_
12-33	2349-2350	a	event[117]|substance[119]	new[117]|new[119]	_	_
12-34	2351-2356	water	event[117]|substance|substance[119]	new[117]|new|new[119]	coref	12-43[122_0]
12-35	2357-2365	molecule	event[117]|substance[119]	new[117]|new[119]	_	_
12-36	2366-2367	.	_	_	_	_
12-37	2368-2373	Zn(II	substance	giv	_	_
12-38	2374-2375	)	_	_	_	_
12-39	2376-2382	lowers	_	_	_	_
12-40	2383-2386	the	quantity[121]	giv[121]	_	_
12-41	2387-2390	pKa	quantity[121]	giv[121]	_	_
12-42	2391-2393	of	quantity[121]	giv[121]	_	_
12-43	2394-2397	the	quantity[121]|substance[122]	giv[121]|giv[122]	_	_
12-44	2398-2403	bound	quantity[121]|substance[122]	giv[121]|giv[122]	_	_
12-45	2404-2409	water	quantity[121]|substance[122]	giv[121]|giv[122]	_	_
12-46	2410-2413	and	_	_	_	_
12-47	2414-2419	forms	_	_	_	_
12-48	2420-2421	a	abstract[124]	new[124]	_	_
12-49	2422-2428	highly	abstract[124]	new[124]	_	_
12-50	2429-2441	nucleophilic	abstract[124]	new[124]	_	_
12-51	2442-2451	hydroxide	animal|abstract[124]	new|new[124]	_	_
12-52	2452-2459	species	abstract[124]	new[124]	_	_
12-53	2460-2465	which	_	_	_	_
12-54	2466-2472	reacts	_	_	_	_
12-55	2473-2477	with	_	_	_	_
12-56	2478-2481	CO2	substance	giv	coref	14-13
12-57	2482-2483	,	_	_	_	_
12-58	2484-2489	bound	_	_	_	_
12-59	2490-2492	in	_	_	_	_
12-60	2493-2498	close	abstract[126]	new[126]	_	_
12-61	2499-2508	proximity	abstract[126]	new[126]	_	_
12-62	2509-2510	,	_	_	_	_
12-63	2511-2513	to	_	_	_	_
12-64	2514-2519	yield	_	_	_	_
12-65	2520-2525	HCO3−	substance	giv	_	_
12-66	2526-2527	.	_	_	_	_

#Text=CA isoforms have been extensively studied due to their clinical importance as drug targets and artificial lungs , and their great potential as catalysts in carbon capture systems .
13-1	2528-2530	CA	_	_	_	_
13-2	2531-2539	isoforms	abstract	new	ana	13-9
13-3	2540-2544	have	_	_	_	_
13-4	2545-2549	been	_	_	_	_
13-5	2550-2561	extensively	_	_	_	_
13-6	2562-2569	studied	_	_	_	_
13-7	2570-2573	due	_	_	_	_
13-8	2574-2576	to	_	_	_	_
13-9	2577-2582	their	abstract|abstract[130]	giv|new[130]	ana	13-20
13-10	2583-2591	clinical	abstract[130]	new[130]	_	_
13-11	2592-2602	importance	abstract[130]	new[130]	_	_
13-12	2603-2605	as	abstract[130]	new[130]	_	_
13-13	2606-2610	drug	abstract[130]|substance	new[130]|new	_	_
13-14	2611-2618	targets	abstract[130]	new[130]	_	_
13-15	2619-2622	and	abstract[130]	new[130]	_	_
13-16	2623-2633	artificial	abstract[130]	new[130]	_	_
13-17	2634-2639	lungs	abstract[130]	new[130]	_	_
13-18	2640-2641	,	abstract[130]	new[130]	_	_
13-19	2642-2645	and	abstract[130]	new[130]	_	_
13-20	2646-2651	their	abstract[130]|abstract	new[130]|giv	_	_
13-21	2652-2657	great	abstract[130]	new[130]	_	_
13-22	2658-2667	potential	abstract[130]	new[130]	_	_
13-23	2668-2670	as	abstract[130]	new[130]	_	_
13-24	2671-2680	catalysts	abstract[130]	new[130]	_	_
13-25	2681-2683	in	abstract[130]	new[130]	_	_
13-26	2684-2690	carbon	abstract[130]|substance|abstract[135]	new[130]|new|giv[135]	_	_
13-27	2691-2698	capture	abstract[130]|event|abstract[135]	new[130]|new|giv[135]	_	_
13-28	2699-2706	systems	abstract[130]|abstract[135]	new[130]|giv[135]	_	_
13-29	2707-2708	.	_	_	_	_

#Text=Especially the latter application drove our interest , as the emission of CO2 and the associated anthropogenic climate change steadily proceeds and new approaches for the absorption of CO2 become increasingly urgent .
14-1	2709-2719	Especially	_	_	_	_
14-2	2720-2723	the	abstract[136]	giv[136]	_	_
14-3	2724-2730	latter	abstract[136]	giv[136]	_	_
14-4	2731-2742	application	abstract[136]	giv[136]	_	_
14-5	2743-2748	drove	_	_	_	_
14-6	2749-2752	our	person|abstract[138]	acc|giv[138]	ana	15-6
14-7	2753-2761	interest	abstract[138]	giv[138]	_	_
14-8	2762-2763	,	_	_	_	_
14-9	2764-2766	as	_	_	_	_
14-10	2767-2770	the	_	_	_	_
14-11	2771-2779	emission	_	_	_	_
14-12	2780-2782	of	_	_	_	_
14-13	2783-2786	CO2	substance	giv	coref	14-29
14-14	2787-2790	and	_	_	_	_
14-15	2791-2794	the	abstract[142]	new[142]	_	_
14-16	2795-2805	associated	abstract[142]	new[142]	_	_
14-17	2806-2819	anthropogenic	abstract|abstract[142]	new|new[142]	_	_
14-18	2820-2827	climate	abstract|abstract[142]	new|new[142]	_	_
14-19	2828-2834	change	abstract[142]	new[142]	_	_
14-20	2835-2843	steadily	_	_	_	_
14-21	2844-2852	proceeds	_	_	_	_
14-22	2853-2856	and	_	_	_	_
14-23	2857-2860	new	abstract[143]	giv[143]	_	_
14-24	2861-2871	approaches	abstract[143]	giv[143]	_	_
14-25	2872-2875	for	abstract[143]	giv[143]	_	_
14-26	2876-2879	the	abstract[143]|abstract[144]	giv[143]|new[144]	coref	15-22[0_144]
14-27	2880-2890	absorption	abstract[143]|abstract[144]	giv[143]|new[144]	_	_
14-28	2891-2893	of	abstract[143]|abstract[144]	giv[143]|new[144]	_	_
14-29	2894-2897	CO2	abstract[143]|abstract[144]|substance	giv[143]|new[144]|giv	coref	15-21[152_0]
14-30	2898-2904	become	_	_	_	_
14-31	2905-2917	increasingly	_	_	_	_
14-32	2918-2924	urgent	_	_	_	_
14-33	2925-2926	.	_	_	_	_

#Text=In order to further increase our understanding of the design of Pep-Au-NPs , and to present a new approach for the absorption CO2 , we herein describe the design and synthesis of the first Pep-Au-NP metalloenzyme mimicking carbonic anhydrase activity .
15-1	2927-2929	In	_	_	_	_
15-2	2930-2935	order	_	_	_	_
15-3	2936-2938	to	_	_	_	_
15-4	2939-2946	further	_	_	_	_
15-5	2947-2955	increase	_	_	_	_
15-6	2956-2959	our	person|abstract[147]	giv|new[147]	ana	15-25
15-7	2960-2973	understanding	abstract[147]	new[147]	_	_
15-8	2974-2976	of	abstract[147]	new[147]	_	_
15-9	2977-2980	the	abstract[147]|abstract[148]	new[147]|new[148]	coref	15-28[154_148]
15-10	2981-2987	design	abstract[147]|abstract[148]	new[147]|new[148]	_	_
15-11	2988-2990	of	abstract[147]|abstract[148]	new[147]|new[148]	_	_
15-12	2991-3001	Pep-Au-NPs	abstract[147]|abstract[148]|object	new[147]|new[148]|giv	_	_
15-13	3002-3003	,	_	_	_	_
15-14	3004-3007	and	_	_	_	_
15-15	3008-3010	to	_	_	_	_
15-16	3011-3018	present	_	_	_	_
15-17	3019-3020	a	abstract[150]	new[150]	_	_
15-18	3021-3024	new	abstract[150]	new[150]	_	_
15-19	3025-3033	approach	abstract[150]	new[150]	_	_
15-20	3034-3037	for	abstract[150]	new[150]	_	_
15-21	3038-3041	the	abstract[150]|substance[152]	new[150]|giv[152]	_	_
15-22	3042-3052	absorption	abstract[150]|abstract|substance[152]	new[150]|giv|giv[152]	_	_
15-23	3053-3056	CO2	abstract[150]|substance[152]	new[150]|giv[152]	_	_
15-24	3057-3058	,	_	_	_	_
15-25	3059-3061	we	person	giv	_	_
15-26	3062-3068	herein	_	_	_	_
15-27	3069-3077	describe	_	_	_	_
15-28	3078-3081	the	abstract[154]|abstract[155]	giv[154]|giv[155]	_	_
15-29	3082-3088	design	abstract[154]|abstract[155]	giv[154]|giv[155]	_	_
15-30	3089-3092	and	abstract[155]	giv[155]	_	_
15-31	3093-3102	synthesis	abstract[155]|abstract[156]	giv[155]|giv[156]	_	_
15-32	3103-3105	of	abstract[155]|abstract[156]	giv[155]|giv[156]	_	_
15-33	3106-3109	the	abstract[155]|abstract[156]|substance[158]	giv[155]|giv[156]|giv[158]	coref	15-39[0_158]
15-34	3110-3115	first	abstract[155]|abstract[156]|substance[158]	giv[155]|giv[156]|giv[158]	_	_
15-35	3116-3125	Pep-Au-NP	abstract[155]|abstract[156]|abstract|substance[158]	giv[155]|giv[156]|new|giv[158]	_	_
15-36	3126-3139	metalloenzyme	abstract[155]|abstract[156]|substance[158]	giv[155]|giv[156]|giv[158]	_	_
15-37	3140-3149	mimicking	_	_	_	_
15-38	3150-3158	carbonic	abstract|abstract[161]	giv|giv[161]	_	_
15-39	3159-3168	anhydrase	substance|abstract[161]	giv|giv[161]	_	_
15-40	3169-3177	activity	abstract[161]	giv[161]	_	_
15-41	3178-3179	.	_	_	_	_
